Journal of Nutrition and Metabolism / 2012 / Article / Tab 2 / Clinical Study
Effects of Oral L-Carnitine Supplementation on Lipid Profile, Anemia, and Quality of Life in Chronic Renal Disease Patients under Hemodialysis: A Randomized, Double-Blinded, Placebo-Controlled Trial Table 2 The changes in lipid profile, hemoglobin, and consumed erythropoietin in two groups.
Carnitine Placebo
š
=
2
4
š
=
2
7
Baseline 8th week 16th week
š
Baseline 8th week 16th week
š
Triglyceride, mg/dL
1
6
5
.
5
Ā±
7
1
.
3
1
4
7
.
2
Ā±
6
0
.
2
1
3
8
.
3
Ā±
5
4
.
3
0.001
1
4
2
.
2
Ā±
5
8
.
0
1
6
1
.
3
Ā±
5
2
.
4
1
5
1
.
8
Ā±
4
8
.
2
0.029 Cholesterol, mg/dL
1
4
7
.
1
Ā±
4
0
.
8
1
5
4
.
0
Ā±
3
0
.
2
1
5
4
.
5
Ā±
3
0
.
1
0.075
1
5
4
.
8
Ā±
2
5
.
1
1
5
5
.
3
Ā±
2
9
.
3
1
5
1
.
2
Ā±
2
4
.
9
0.517 HD, mg/dL
3
0
.
2
Ā±
6
.
6
3
1
.
0
Ā±
5
.
8
3
4
.
0
Ā±
6
.
6
<0.001
2
9
.
5
Ā±
7
.
2
3
0
.
1
Ā±
6
.
1
2
8
.
6
Ā±
8
.
4
0.185 LDL, mg/dL
8
4
.
0
Ā±
2
4
.
7
8
3
.
5
Ā±
2
0
.
2
8
1
.
0
Ā±
2
0
.
7
0.237
9
7
.
6
Ā±
2
6
.
1
9
2
.
1
Ā±
3
0
.
0
9
0
.
6
Ā±
2
8
.
9
0.227 Hemoglobin, mg/dL
1
0
.
5
Ā±
2
.
5
1
0
.
9
Ā±
2
.
4
1
1
.
3
Ā±
2
.
1
0.081
9
.
5
Ā±
2
.
2
1
0
.
1
Ā±
1
.
9
9
.
9
Ā±
2
.
5
0.145 Dose of erythropoietin, U/wk
7
2
5
0
Ā±
5
2
0
2
4
7
5
0
Ā±
3
8
1
3
2
5
0
0
Ā±
4
1
8
0
<0.001
8
0
0
0
Ā±
3
1
8
6
6
8
8
8
Ā±
4
3
0
8
6
0
0
0
Ā±
5
0
8
3
0.033
